Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF)
- 24 May 2007
- journal article
- Published by Elsevier in Life Sciences
- Vol. 81 (3) , 210-217
- https://doi.org/10.1016/j.lfs.2007.05.003
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the “do ut des” paradigm)Critical Reviews in Oncology/Hematology, 2006
- Macrophages promote angiogenesis in human breast tumour spheroids in vivoBritish Journal of Cancer, 2005
- Receptor for platelet-activating factor (PAF) is not detectable by flow cytometry on the surface of myeloid leukemic cellsAnnals of Hematology, 2005
- Inhibition of inflammatory angiogenesis by distant subcutaneous tumor in miceLife Sciences, 2004
- Platelet‐activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migrationThe FASEB Journal, 2004
- Recruitment of Murine Neutrophils in Vivothrough Endogenous Sialidase ActivityPublished by Elsevier ,2003
- Inflammation and cancer: back to Virchow?The Lancet, 2001
- PAF Produced by Human Breast Cancer Cells Promotes Migration and Proliferation of Tumor Cells and Neo-AngiogenesisThe American Journal of Pathology, 2000
- Platelet-activating factor in human endometriumThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- [29] Sponge implants as modelsPublished by Elsevier ,1988